Sunday, July 12, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “inhibitors”

2,466 pharma patents match "inhibitors" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,466
Index total 30,257
Page 28 / 103

Quick answer

This filtered view shows 2,466 pharmaceutical patents matching "inhibitors" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,466 results for “inhibitors” · 30,257 patents in full index Clear search

  1. US 10906916

    Thienopyrimidinones as ubiquitin-specific protease 7 inhibitors

    Valo Early Discovery, Inc. · Granted Feb 2, 2021 · Expires Jan 28, 2041

    granted

  2. US 10906914

    Furoquinolinediones as inhibitors of TDP2

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 2, 2021 · Expires Jan 28, 2041

    granted

  3. US 10899738

    Piperidines as menin inhibitors

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jan 26, 2021 · Expires Jan 21, 2041

    granted

  4. US 10898475

    Bach1 inhibitors in combination with Nrf2 activators and pharmaceutical compositions thereof

    VTV THERAPEUTICS LLC · Granted Jan 26, 2021 · Expires Jan 21, 2041

    granted

  5. US 10894797

    Fused tricyclic ring derivatives as SRC homology-2 phosphatase inhibitors

    NIKANG THERAPEUTICS, INC. · Granted Jan 19, 2021 · Expires Jan 14, 2041

    granted

  6. US 10894052

    Heterocyclic inhibitors of ATR kinase

    The Board of Regents of the University of Texas System · Granted Jan 19, 2021 · Expires Jan 14, 2041

    granted

  7. US 10894786

    Substituted pyrazole derivatives as selective CDK12/13 inhibitors

    Aurigene Discovery Technologies Limited · Granted Jan 19, 2021 · Expires Jan 14, 2041

    granted

  8. US 10894044

    Combination of topoisomerase-I inhibitors with immunotherapy in the treatment of cancer

    The Board of Regents of the University of Texas System · Granted Jan 19, 2021 · Expires Jan 14, 2041

    granted

  9. US 10889592

    Thienopyrazine carboxamides as ubiquitin-specific protease inhibitors

    Valo Early Discovery, Inc. · Granted Jan 12, 2021 · Expires Jan 7, 2041

    granted

  10. US 10888609

    CD200 inhibitors and methods of use thereof

    Regents of the University of Minnesota · Granted Jan 12, 2021 · Expires Jan 7, 2041

    granted

  11. US 10881669

    Inhibitors of the plasmodial surface anion channel as antimalarials

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 5, 2021 · Expires Dec 31, 2040

    granted

  12. US 10881666

    Combination pharmaceutical agents as RSV inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Jan 5, 2021 · Expires Dec 31, 2040

    granted

  13. US 10874648

    Methods for the administration of certain VMAT2 inhibitors

    Neurocrine Biosciences, Inc. · Granted Dec 29, 2020 · Expires Dec 24, 2040

    granted

  14. US 10875855

    Inhibitors of influenza viruses replication

    Vertex Pharmaceuticals Incorporated · Granted Dec 29, 2020 · Expires Dec 24, 2040

    granted

  15. US 10874673

    Inhibitors of influenza viruses replication

    Vertex Pharmaceuticals Incorporated · Granted Dec 29, 2020 · Expires Dec 24, 2040

    granted

  16. US 10874649

    2-spiro-5- and 6-hydroxamic acid indanes as HDAC inhibitors

    Valo Early Discovery, Inc. · Granted Dec 29, 2020 · Expires Dec 24, 2040

    granted

  17. US 10869865

    Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria

    The United States of America, as represented by the Secretary, Department of Health and Human Serv · Granted Dec 22, 2020 · Expires Dec 17, 2040

    granted

  18. US 10870645

    Bicyclic [4,6,0] hydroxamic acids as HDAC inhibitors

    Valo Early Discovery, Inc. · Granted Dec 22, 2020 · Expires Dec 17, 2040

    granted

  19. US 10864222

    Beta-lactamase inhibitors, formulations, and uses thereof

    The Regents of the University of California · Granted Dec 15, 2020 · Expires Dec 10, 2040

    granted

  20. US 10865215

    Benzodiazepine derivatives as RSV inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Dec 15, 2020 · Expires Dec 10, 2040

    granted

  21. US 10858335

    2,3-Disubstituted pyridine compounds as TGF-β inhibitors and methods of use

    Rigel Pharmaceuticals, Inc. · Granted Dec 8, 2020 · Expires Dec 3, 2040

    granted

  22. US 10858323

    HDAC inhibitors for the treatment of diabetic peripheral neuropathy

    Regenacy Pharmaceuticals, Inc. · Granted Dec 8, 2020 · Expires Dec 3, 2040

    granted

  23. US 10857137

    Methods for the administration of certain VMAT2 inhibitors

    Neurocrine Biosciences, Inc. · Granted Dec 8, 2020 · Expires Dec 3, 2040

    granted

  24. US 10857148

    Methods for the administration of certain VMAT2 inhibitors

    Neurocrine Biosciences, Inc. · Granted Dec 8, 2020 · Expires Dec 3, 2040

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.